The use of an LHRH Agonist in the Treatment and Investigation of the Premenstrual Syndrome
The premenstrual syndrome (PMS) remains an enigma. It has as yet eluded satisfactory definition+. The symptoms are protean, involving psychological states such as irritability, depression, tiredness, feelings of abdominal bloatedness, tender swollen breasts, headaches, appetite change, especially carbohydrate craving, changes in bowel and bladder function, allergic reactions, acne, reduced resistance to infections and others. Their temporal relationship with the menstrual cycle is also variable, though symptoms are usually confined to the second half of the cycle declining soon after the onset of menstruation.
KeywordsOvarian Cycle Menstrual Bleeding Ovarian Activity Premenstrual Syndrome LHRH Agonist
Unable to display preview. Download preview PDF.
- Chamberlain, J. and Contractor, S. F., 1968, A gas liquid Chromatographic method for the rapid estimation of pregnanediol and alopregnanediol in non-pregnant urine, Am. J. Obstet. Gynecol., 101:649.Google Scholar
- Dalton, K., 1984, Premenstrual Syndrome and Progesterone Therapy, 2nd ed, Heinemann, London.Google Scholar
- Muse, K. N., Cetel, N. S., Futterman, L. A. and Yen, S. S. C., 1974, The Premenstrual Syndrome. Effects of “medical ovariectomy”. N. Engl. J. Med., 22:1345.Google Scholar